![5 big analyst AI moves: Google downgraded as Apple gets vote of confidence](https://i-invdn-com.investing.com/news/moved_small-LYNXNPEK3H0FI_L.jpg)
Please try another search
Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd., a biopharmaceutical company, engages in the research, development, production, and sale of pharmaceutical products for the diagnosis and treatment of allergic diseases in China and internationally. The company offers Changdi, a farinae farinae drops; Changhao, an artemisia annua pollen allergen sublingual drops; Changdian, a dust mite skin prick diagnostic kits; and Changdian II, a house dust mite skin pricking diagnostic kits. It also involved in the research and development of stem cells and medical artificial intelligence solutions. The company was founded in 2002 and is headquartered in Huzhou, China.
Name | Age | Since | Title |
---|---|---|---|
Gengxi Hu | 58 | 2011 | Chairman & GM |
Yanni Chen | 57 | 2011 | Non-Independent Director |
Lu Zhang | 43 | 2011 | Deputy GM & Non-Independent Director |
Guoliang Xu | 58 | 2020 | Independent Director |
Huifeng Yang | 29 | 2017 | Supervisor |
Ziqiang Bi | 59 | 2022 | Deputy GM & Non-Independent Director |
Feida Zhang | 43 | 2022 | Independent Director |
Tao Jin | 38 | 2017 | Chair of the Supervisory Board |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review